Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02162 KEYMED BIO-B > Detailed Quotes

02162 KEYMED BIO-B

36.450
+0.850+2.39%
Closed 10/03 16:08 CCT
High
36.450
Open
35.600
Turnover
4.98M
Low
34.350
Pre Close
35.600
Volume
140.50K
Market Cap
10.20B
P/E(TTM)
Loss
52wk High
54.250
Shares
279.74M
P/E(Static)
Loss
52wk Low
16.900
Float Cap
10.20B
Bid/Ask %
-4.35%
Historical High
79.800
Shs Float
279.74M
Volume Ratio
0.76
Historical Low
16.900
Dividend TTM
--
Div Yield TTM
--
P/B
2.39
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.05%
Amplitude
5.90%
Avg Price
35.451
Lot Size
500
Float Cap
10.20B
Bid/Ask %
-4.35%
Historical High
79.800
Shs Float
279.74M
Volume Ratio
0.76
Historical Low
16.900
Dividend TTM
--
P/B
2.39
Dividend LFY
--
Turnover Ratio
0.05%
Amplitude
5.90%
Avg Price
35.451
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Keymed Biosciences Inc is a Chinese biotechnology company. The company focuses on finding and developing innovative biotherapies to meet unmet medical needs in the field of autoimmunity and oncology therapy. The company has mastered in-house drug discovery and development technologies, including those that make up its innovative antibody discovery platform and its own new T cell redirection (nTCE) bispecific antibody platform. The company has also established a fully integrated platform covering key functions of biopharmaceutical development. The company's main products include CM310, CM326 and CMG901.
CEO: Bo CHEN
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...